Status:

UNKNOWN

Dexamethasone and Oxygen Support Strategies in ICU Patients With Covid-19 Pneumonia

Lead Sponsor:

Assistance Publique - Hôpitaux de Paris

Conditions:

Acute Hypoxemic Respiratory Failure

COVID-19

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The main manifestation of COVID-19 is acute hypoxemic respiratory failure (AHRF). In patients with AHRF, the need for invasive mechanical ventilation is associated with high mortality. Two hypotheses...

Detailed Description

The main manifestation of COVID-19 is acute hypoxemic respiratory failure (AHRF). In patients with AHRF, the need for invasive mechanical ventilation is associated with high mortality. Two hypotheses...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Age ≥ 18 years
  • Admitted to ICU within 48 hours
  • Confirmed or highly suspected COVID-19 infection
  • Acute hypoxemic respiratory failure (PaO2 \<70 mmHg or SpO2\<90% on room air or tachypnea\>30/min or labored breathing or respiratory distress; need for oxygen flow \>=6L/min)
  • Any treatment intended to treat the SARS-CoV-2 infection in the absence of contraindications (either as a compassionate use or in the context of a clinical trial, i.e remdesivir, lopinavir/ritonavir, favipiravir, hydroxychloroquine and any other new drug with potential activity).
  • Non-inclusion Criteria:
  • Moribund status
  • Pregnancy or breastfeeding
  • Long term corticotherapy at a dose of 0.5mg/kg/j or higher
  • Active and untreated bacterial, fungal or parasitic infection
  • Not Written informed consent from the patient or a legal representative if appropriate . If absence a legal representative the patient may be included in emergency procedure
  • hypersensitivity to dexamethasone or to any of the excipients
  • Not Affiliation to the French social security

Exclusion

    Key Trial Info

    Start Date :

    April 10 2020

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    December 31 2021

    Estimated Enrollment :

    550 Patients enrolled

    Trial Details

    Trial ID

    NCT04344730

    Start Date

    April 10 2020

    End Date

    December 31 2021

    Last Update

    February 9 2021

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Hopital Bichat - Aphp

    Paris, France, 75018

    Dexamethasone and Oxygen Support Strategies in ICU Patients With Covid-19 Pneumonia | DecenTrialz